AAPL308.63+14.25 (+4.84%) ▲|ABBV261.07+10.01 (+3.99%) ▲|ABT95.40+3.22 (+3.49%) ▲|ACN137.35+6.22 (+4.74%) ▲|ADBE219.72+8.74 (+4.14%) ▲|AMAT603.04-47.87 (-7.35%) ▼|AMD517.82-23.06 (-4.26%) ▼|AMGN374.15+12.82 (+3.55%) ▲|AMT166.03-0.05 (-0.03%) ▼|AMZN242.67+0.97 (+0.40%) ▲|AVGO360.45-8.89 (-2.41%) ▼|AXP351.96+4.91 (+1.41%) ▲|BA226.49+7.91 (+3.62%) ▲|BAC58.73+0.37 (+0.63%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK995.73+15.35 (+1.57%) ▲|BMY58.13+2.32 (+4.16%) ▲|BNY146.62+0.60 (+0.41%) ▲|BRK-B507.78+8.04 (+1.61%) ▲|C139.97-0.16 (-0.11%) ▼|CAT963.53-27.88 (-2.81%) ▼|CL95.13+2.37 (+2.56%) ▲|CMCSA23.79+0.06 (+0.25%) ▲|COF205.12+0.30 (+0.15%) ▲|COP104.73+1.51 (+1.46%) ▲|COST951.67+27.00 (+2.92%) ▲|CRM166.11+2.88 (+1.76%) ▲|CSCO112.69-4.32 (-3.69%) ▼|CVS104.72-0.09 (-0.09%) ▼|CVX169.20+3.51 (+2.12%) ▲|DE621.27-6.36 (-1.01%) ▼|DHR197.93+4.21 (+2.17%) ▲|DIS99.50+3.79 (+3.96%) ▲|DUK129.60+3.83 (+3.05%) ▲|EMR139.05-0.47 (-0.34%) ▼|FDX313.00-0.89 (-0.28%) ▼|GD373.54+12.27 (+3.40%) ▲|GE377.52+2.58 (+0.69%) ▲|GEV1,113.11-21.24 (-1.87%) ▼|GILD131.27+5.30 (+4.21%) ▲|GM76.00+0.48 (+0.64%) ▲|GOOG356.18-1.71 (-0.48%) ▼|GOOGL359.91-1.30 (-0.36%) ▼|GS1,021.00+1.39 (+0.14%) ▲|HD357.90+7.06 (+2.01%) ▲|HON229.86+8.11 (+3.66%) ▲|IBM289.52+3.27 (+1.14%) ▲|INTC120.35-6.67 (-5.25%) ▼|INTU275.35+8.27 (+3.10%) ▲|ISRG426.01+23.63 (+5.87%) ▲|JNJ263.04+9.06 (+3.57%) ▲|JPM334.47+0.40 (+0.12%) ▲|KO84.14+2.85 (+3.51%) ▲|LIN546.64+13.09 (+2.45%) ▲|LLY1,213.91+22.17 (+1.86%) ▲|LMT545.91+24.09 (+4.62%) ▲|LOW227.50+5.58 (+2.51%) ▲|LRCX351.41-39.85 (-10.19%) ▼|MA539.39+16.95 (+3.24%) ▲|MCD280.63+11.20 (+4.16%) ▲|MDLZ60.91+1.56 (+2.63%) ▲|MDT83.19+3.99 (+5.04%) ▲|META582.90-30.01 (-4.90%) ▼|MMM160.44+0.48 (+0.30%) ▲|MO72.71+1.17 (+1.64%) ▲|MRK129.56+4.19 (+3.34%) ▲|MS213.93+2.07 (+0.98%) ▲|MSFT390.49+6.21 (+1.62%) ▲|MU975.56-56.72 (-5.49%) ▼|NEE88.34+1.97 (+2.28%) ▲|NFLX77.65+3.46 (+4.66%) ▲|NKE44.09+1.03 (+2.39%) ▲|NOW106.32+0.52 (+0.49%) ▲|NVDA194.83-2.75 (-1.39%) ▼|ORCL140.27-2.23 (-1.56%) ▼|PEP144.22+3.06 (+2.17%) ▲|PFE24.32+0.44 (+1.84%) ▲|PG151.41+3.98 (+2.70%) ▲|PLTR129.30+3.57 (+2.84%) ▲|PM182.27+4.58 (+2.58%) ▲|QCOM176.25-5.67 (-3.12%) ▼|RTX199.25+7.47 (+3.90%) ▲|SBUX104.27+0.88 (+0.85%) ▲|SCHW97.00+1.22 (+1.27%) ▲|SO97.98+2.86 (+3.01%) ▲|SPG226.06+3.06 (+1.37%) ▲|T20.58+0.10 (+0.49%) ▲|TMO523.44+10.11 (+1.97%) ▲|TMUS177.52+4.46 (+2.58%) ▲|TSLA393.45-31.85 (-7.49%) ▼|TXN293.08-5.33 (-1.79%) ▼|UBER74.43+1.77 (+2.44%) ▲|UNH425.36-1.18 (-0.28%) ▼|UNP282.25+4.52 (+1.63%) ▲|UPS110.66+1.12 (+1.02%) ▲|USB61.73-0.23 (-0.37%) ▼|V362.13+11.05 (+3.15%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.51-0.43 (-0.50%) ▼|WMT111.84+3.02 (+2.78%) ▲|XOM137.09+0.81 (+0.59%) ▲|AAPL308.63+14.25 (+4.84%) ▲|ABBV261.07+10.01 (+3.99%) ▲|ABT95.40+3.22 (+3.49%) ▲|ACN137.35+6.22 (+4.74%) ▲|ADBE219.72+8.74 (+4.14%) ▲|AMAT603.04-47.87 (-7.35%) ▼|AMD517.82-23.06 (-4.26%) ▼|AMGN374.15+12.82 (+3.55%) ▲|AMT166.03-0.05 (-0.03%) ▼|AMZN242.67+0.97 (+0.40%) ▲|AVGO360.45-8.89 (-2.41%) ▼|AXP351.96+4.91 (+1.41%) ▲|BA226.49+7.91 (+3.62%) ▲|BAC58.73+0.37 (+0.63%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK995.73+15.35 (+1.57%) ▲|BMY58.13+2.32 (+4.16%) ▲|BNY146.62+0.60 (+0.41%) ▲|BRK-B507.78+8.04 (+1.61%) ▲|C139.97-0.16 (-0.11%) ▼|CAT963.53-27.88 (-2.81%) ▼|CL95.13+2.37 (+2.56%) ▲|CMCSA23.79+0.06 (+0.25%) ▲|COF205.12+0.30 (+0.15%) ▲|COP104.73+1.51 (+1.46%) ▲|COST951.67+27.00 (+2.92%) ▲|CRM166.11+2.88 (+1.76%) ▲|CSCO112.69-4.32 (-3.69%) ▼|CVS104.72-0.09 (-0.09%) ▼|CVX169.20+3.51 (+2.12%) ▲|DE621.27-6.36 (-1.01%) ▼|DHR197.93+4.21 (+2.17%) ▲|DIS99.50+3.79 (+3.96%) ▲|DUK129.60+3.83 (+3.05%) ▲|EMR139.05-0.47 (-0.34%) ▼|FDX313.00-0.89 (-0.28%) ▼|GD373.54+12.27 (+3.40%) ▲|GE377.52+2.58 (+0.69%) ▲|GEV1,113.11-21.24 (-1.87%) ▼|GILD131.27+5.30 (+4.21%) ▲|GM76.00+0.48 (+0.64%) ▲|GOOG356.18-1.71 (-0.48%) ▼|GOOGL359.91-1.30 (-0.36%) ▼|GS1,021.00+1.39 (+0.14%) ▲|HD357.90+7.06 (+2.01%) ▲|HON229.86+8.11 (+3.66%) ▲|IBM289.52+3.27 (+1.14%) ▲|INTC120.35-6.67 (-5.25%) ▼|INTU275.35+8.27 (+3.10%) ▲|ISRG426.01+23.63 (+5.87%) ▲|JNJ263.04+9.06 (+3.57%) ▲|JPM334.47+0.40 (+0.12%) ▲|KO84.14+2.85 (+3.51%) ▲|LIN546.64+13.09 (+2.45%) ▲|LLY1,213.91+22.17 (+1.86%) ▲|LMT545.91+24.09 (+4.62%) ▲|LOW227.50+5.58 (+2.51%) ▲|LRCX351.41-39.85 (-10.19%) ▼|MA539.39+16.95 (+3.24%) ▲|MCD280.63+11.20 (+4.16%) ▲|MDLZ60.91+1.56 (+2.63%) ▲|MDT83.19+3.99 (+5.04%) ▲|META582.90-30.01 (-4.90%) ▼|MMM160.44+0.48 (+0.30%) ▲|MO72.71+1.17 (+1.64%) ▲|MRK129.56+4.19 (+3.34%) ▲|MS213.93+2.07 (+0.98%) ▲|MSFT390.49+6.21 (+1.62%) ▲|MU975.56-56.72 (-5.49%) ▼|NEE88.34+1.97 (+2.28%) ▲|NFLX77.65+3.46 (+4.66%) ▲|NKE44.09+1.03 (+2.39%) ▲|NOW106.32+0.52 (+0.49%) ▲|NVDA194.83-2.75 (-1.39%) ▼|ORCL140.27-2.23 (-1.56%) ▼|PEP144.22+3.06 (+2.17%) ▲|PFE24.32+0.44 (+1.84%) ▲|PG151.41+3.98 (+2.70%) ▲|PLTR129.30+3.57 (+2.84%) ▲|PM182.27+4.58 (+2.58%) ▲|QCOM176.25-5.67 (-3.12%) ▼|RTX199.25+7.47 (+3.90%) ▲|SBUX104.27+0.88 (+0.85%) ▲|SCHW97.00+1.22 (+1.27%) ▲|SO97.98+2.86 (+3.01%) ▲|SPG226.06+3.06 (+1.37%) ▲|T20.58+0.10 (+0.49%) ▲|TMO523.44+10.11 (+1.97%) ▲|TMUS177.52+4.46 (+2.58%) ▲|TSLA393.45-31.85 (-7.49%) ▼|TXN293.08-5.33 (-1.79%) ▼|UBER74.43+1.77 (+2.44%) ▲|UNH425.36-1.18 (-0.28%) ▼|UNP282.25+4.52 (+1.63%) ▲|UPS110.66+1.12 (+1.02%) ▲|USB61.73-0.23 (-0.37%) ▼|V362.13+11.05 (+3.15%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.51-0.43 (-0.50%) ▼|WMT111.84+3.02 (+2.78%) ▲|XOM137.09+0.81 (+0.59%) ▲|
37.4 C
New York
Friday, July 3, 2026

Tag: SAFE

newssourceFORcompanyinformationcontent1releasesmarket

WySE Products Launches Total Pet Kitchen, The First-of-Its-Kind Multicooker for Fresh Pet Food Preparation at Home

Englewood Cliffs, NJ, June 23, 2025 (GLOBE NEWSWIRE) -- WySE Products LLC, a company committed to redefining pet nutrition, is pleased to announce the launch of Total Pet Kitchen Multicooker (TPK), the first-of-its-kind countertop appliance designed specifically for cooking and dispensing healthy food for pets using human-grade ingredients.

Zendure’s ZENKI-Powered SolarFlow Sets New Standards for Self-Sufficiency This Solstice

DÜSSELDORF, Germany, June 23, 2025 /PRNewswire/ -- As the June 21 summer solstice brings up to 16 hours of daylight, Zendure, a leading EnergyTech innovator, spotlights...

APP Group Shares Paperboard Advancements Amid U.S. Biodegradable Packaging Market Growth

JAKARTA, Indonesia , June 23, 2025 /PRNewswire/ -- As proud members of the Paperboard Packaging Council (PPC), APP Group (APP) and Charta Global Inc., its...

Toshiba Showcases Innovative SCiB™ Lithium-Ion Battery at ASIA Sustainable Energy Week 2025

Empowering Greener Transport, Logistics, and Infrastructure for a Decarbonized Future BANGKOK, June 23, 2025 /PRNewswire/ -- Toshiba Corporation announces its participation in ASIA Sustainable Energy Week 2025...

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Bagsværd, Denmark, 22 June 2025 – Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout period or Mim8 loading dose, was well-tolerated with no safety concerns in adults and adolescents living with haemophilia A, with or without inhibitors1. Additionally, a FRONTIER5 Patient-Reported Outcomes (PROs) assessment found the Mim8 pen-injector easy to use, with an overall strong user preference for the pen-injector compared to the previous emicizumab injection system2,3. The results were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

SK Group and AWS Team Up to Build Cloud Computing Infrastructure to Support AI Innovation

SK Group, in partnership with AWS, will provide data center infrastructure for a new AWS AI Zone location in Ulsan that will support AI...

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

Debt Consolidation Loan for Poor Credit Score: Radcred Instant Funding Solution with No Credit Check & Same-Day Loan

Simplify your finances by consolidating high-interest debt into one low-interest loan. Apply today with Radcred for fast relief and better financial management. 
Simplify your finances by consolidating high-interest debt into one low-interest loan. Apply today with Radcred for fast relief and better financial management.

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.

Kaanch Network Presale Positions Project Among Top Altcoins and Best Crypto Opportunities of 2025

DUBAI, United Arab Emirates, June 21, 2025 (GLOBE NEWSWIRE) -- Kaanch Network’s token is set to be listed on BitMart and LBank exchanges on June 30th, an important milestone in the project’s mission to revolutionize decentralized finance and asset management. Built on a scalable and affordable Layer 1 blockchain with real-world applications, Kaanch offers developers, business owners, and investors a compelling platform for growth in 2025 and beyond.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSAFE

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers